RXRX EBITDA Growth
Recursion Pharmaceuticals Inc Clas · EBITDA Growth
RXRX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported23.85%period ending
RXRX TTM EBITDA YoY % (-115.66% → 23.85%)
Year-over-year change
High-resolution chart · PNG
RXRX ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 23.8494% | |
| 8.6304% | |
| -31.2807% | |
| -81.5328% | |
| -67.5449% | |
| -58.635% | |
| -38.7126% | |
| -28.7948% | |
| -42.5055% | |
| -40.1435% | |
| -35.1238% | |
| -15.3737% | |
| -9.3982% | |
| -18.4653% | |
| -30.0035% | |
| -73.2104% | |
| -95.7288% | |
| -114.057% | |
| -115.6554% |